On the pathophysiology of vitiligo

Possible treatment options

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Vitiligo is an acquired depigmenting disorder usually classified as non-segmental and segmental types with a higher incidence of the non-segmental ones. The cause of non-segmental vitiligo is still unknown. Currently, it is a dogma that there are several genes affecting the immune system and the pigment system that predisposes someone to develop vitiligo. A precipitating factor must then ellicit an interaction between the immune system and the melanocyte, resulting in destruction of the melanocyte population in discrete areas of the skin. Starting from the overlapping but distinct pathomechanisms, treatment should be finalized to the cellular targets and possibly related to the disease phase.

Original languageEnglish
Pages (from-to)24-29
Number of pages6
JournalIndian Journal of Dermatology, Venereology and Leprology
Volume78
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Vitiligo
Melanocytes
Immune System
Precipitating Factors
Skin
Incidence
Population
Genes

Keywords

  • Pathogenesis
  • treatment options
  • vitiligo

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

On the pathophysiology of vitiligo : Possible treatment options. / Boissy, Raymond E.; Dell'anna, Maria Lucia; Picardo, Mauro.

In: Indian Journal of Dermatology, Venereology and Leprology, Vol. 78, No. 1, 01.2012, p. 24-29.

Research output: Contribution to journalArticle

@article{9ecff9aba14c4bc5919e72c00b9ffc78,
title = "On the pathophysiology of vitiligo: Possible treatment options",
abstract = "Vitiligo is an acquired depigmenting disorder usually classified as non-segmental and segmental types with a higher incidence of the non-segmental ones. The cause of non-segmental vitiligo is still unknown. Currently, it is a dogma that there are several genes affecting the immune system and the pigment system that predisposes someone to develop vitiligo. A precipitating factor must then ellicit an interaction between the immune system and the melanocyte, resulting in destruction of the melanocyte population in discrete areas of the skin. Starting from the overlapping but distinct pathomechanisms, treatment should be finalized to the cellular targets and possibly related to the disease phase.",
keywords = "Pathogenesis, treatment options, vitiligo",
author = "Boissy, {Raymond E.} and Dell'anna, {Maria Lucia} and Mauro Picardo",
year = "2012",
month = "1",
doi = "10.4103/0378-6323.90943",
language = "English",
volume = "78",
pages = "24--29",
journal = "Indian Journal of Dermatology, Venereology and Leprology",
issn = "0378-6323",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - On the pathophysiology of vitiligo

T2 - Possible treatment options

AU - Boissy, Raymond E.

AU - Dell'anna, Maria Lucia

AU - Picardo, Mauro

PY - 2012/1

Y1 - 2012/1

N2 - Vitiligo is an acquired depigmenting disorder usually classified as non-segmental and segmental types with a higher incidence of the non-segmental ones. The cause of non-segmental vitiligo is still unknown. Currently, it is a dogma that there are several genes affecting the immune system and the pigment system that predisposes someone to develop vitiligo. A precipitating factor must then ellicit an interaction between the immune system and the melanocyte, resulting in destruction of the melanocyte population in discrete areas of the skin. Starting from the overlapping but distinct pathomechanisms, treatment should be finalized to the cellular targets and possibly related to the disease phase.

AB - Vitiligo is an acquired depigmenting disorder usually classified as non-segmental and segmental types with a higher incidence of the non-segmental ones. The cause of non-segmental vitiligo is still unknown. Currently, it is a dogma that there are several genes affecting the immune system and the pigment system that predisposes someone to develop vitiligo. A precipitating factor must then ellicit an interaction between the immune system and the melanocyte, resulting in destruction of the melanocyte population in discrete areas of the skin. Starting from the overlapping but distinct pathomechanisms, treatment should be finalized to the cellular targets and possibly related to the disease phase.

KW - Pathogenesis

KW - treatment options

KW - vitiligo

UR - http://www.scopus.com/inward/record.url?scp=84861054601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861054601&partnerID=8YFLogxK

U2 - 10.4103/0378-6323.90943

DO - 10.4103/0378-6323.90943

M3 - Article

VL - 78

SP - 24

EP - 29

JO - Indian Journal of Dermatology, Venereology and Leprology

JF - Indian Journal of Dermatology, Venereology and Leprology

SN - 0378-6323

IS - 1

ER -